cancer research
Researchers claim their invention offers a cost-effective and faster way to do single-cell analysis.
The partnership aims to investigate the role genetics play in developing personalised cancer treatments
Florent Chandelier, chief technology officer at Imagia, talks about how his company uses AI and real-world data to help propel research and care.
Boston-based Syntropy will create a digital platform that allows cancer researchers to share and analyze data from numerous different organizations.